Crucial Data Solutions Enhances eClinical Platform to Further Support Virtual Clinical Trials

The TrialKit platform received updates to its eConsent and ePRO modules to advance remote data collection and management

Crucial Data Solutions, Inc. (CDS), a provider of innovative software to advance clinical research, announced today a number of enhancements to their data collection and study management platform, TrialKit. The platform’s electronic informed consent (eConsent) and electronic patient-reported outcomes (ePRO) modules were updated to optimize efficiency, enable enhanced workflows and improve the user experience for both research professionals and patients.

“With the growing demand for remote data entry, information access, and management activities by site staff, study teams, and patients throughout the course of a clinical trial, the release of enhanced features for ePRO, eCOA, and eConsent activities in the TrialKit platform could not have come at a better time,” said Jeff Rogers, President of CDS. “The impact of the COVID-19 pandemic has accelerated the need for the versatility that TrialKit offers within its web-based eClinical platform and its downloadable, native mobile app. CDS continues to lead the way with out-of-box features and innovation that meet the needs of our global client base in an ever-changing world.”

TrialKit’s new multilingual functionality

TrialKit’s eConsent and ePRO modules make it easy to participate and provide data anytime, anywhere. eConsent allows trial participants to consent remotely on a smartphone or tablet. And, as part of the updated features, patients will now be prompted to provide consent before proceeding with additional data submission. Additional features include:

  • Study-specific consent using embedded site-specific documents, video links, images, or text 
  • Ability to contact participants for supplemental data regarding consent, such as comprehension questions or availability dates, followed by electronic participant signature 
  • Consent tracking throughout the study as new consent is required by protocol and other mid-study changes 
  • Access by researchers to view participant consent and history in one combined report

To support a wider variety of study designs, the ePRO feature in TrialKit has also gained greater flexibility through enhanced configurations. This flexibility affects:

  • Electronic case report forms (eCRFs), which can now be delivered at specific days/times, specific recurring intervals, or based on trigger events that occur in any diary or part of the study completed by the same patient
  • Notification to participants about new eCRFs, which can now be delivered using customized messages via email or in-app push notifications

Multilingual functionality is also now available on TrialKit’s native mobile app. The iOS version of the app can be accessed in English, Spanish, German, French, and Chinese. This functionality is coming soon to the Android version of TrialKit.

“Unique to TrialKit’s mobile app interface, language is device-dependent – not account-dependent – so a single study may utilize multiple languages, making international virtual trials more achievable,” said Cody Wilke, VP of Product Management at CDS. “This feature, which allows data to be collected in the patient’s native language, enables more accurate, efficient collection of patient-reported outcomes.”  

To learn more about TrialKit, view the video that explains how the platform fully enables virtual trials across all clinical trial phases.

About Crucial Data Solutions

Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative and affordable data collection and clinical trial management technology on the market today. TrialKit, our cloud-based platform available via a web interface and downloadable native mobile app, enables end-to-end clinical trial management for pharmaceutical, biotechnology, and medical device companies of all sizes. Design and deploy regulatory compliant studies in days instead of weeks using our intuitive forms designer that requires no programming. Over 10,000 global users have leveraged the flexibility of TrialKit to deploy over 1,100 studies across all phases of clinical development. Learn more about CDS at

Related Posts